Intratumoral microbiome of adenoid cystic carcinomas and comparison with other head and neck cancers.
Bacteroides thetaiotaomicron
Bacterial
Mucus layer
Oral
Tumors
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 Jul 2024
15 Jul 2024
Historique:
received:
26
03
2024
accepted:
25
06
2024
medline:
16
7
2024
pubmed:
16
7
2024
entrez:
15
7
2024
Statut:
epublish
Résumé
Adenoid cystic carcinoma (ACC) is a rare, usually slow-growing yet aggressive head and neck malignancy. Despite its clinical significance, our understanding of the cellular evolution and microenvironment in ACC remains limited. We investigated the intratumoral microbiomes of 50 ACC tumor tissues and 33 adjacent normal tissues using 16S rRNA gene sequencing. This allowed us to characterize the bacterial communities within the ACC and explore potential associations between the bacterial community structure, patient clinical characteristics, and tumor molecular features obtained through RNA sequencing. The bacterial composition in the ACC was significantly different from that in adjacent normal salivary tissue, and the ACC exhibited diverse levels of species richness. We identified two main microbial subtypes within the ACC: oral-like and gut-like. Oral-like microbiomes, characterized by increased diversity and abundance of Neisseria, Leptotrichia, Actinomyces, Streptococcus, Rothia, and Veillonella (commonly found in healthy oral cavities), were associated with a less aggressive ACC-II molecular subtype and improved patient outcomes. Notably, we identified the same oral genera in oral cancer and head and neck squamous cell carcinomas. In both cancers, they were part of shared oral communities associated with a more diverse microbiome, less aggressive tumor phenotype, and better survival that reveal the genera as potential pancancer biomarkers for favorable microbiomes in ACC and other head and neck cancers. Conversely, gut-like intratumoral microbiomes, which feature low diversity and colonization by gut mucus layer-degrading species, such as Bacteroides, Akkermansia, Blautia, Bifidobacterium, and Enterococcus, were associated with poorer outcomes. Elevated levels of Bacteroides thetaiotaomicron were independently associated with significantly worse survival and positively correlated with tumor cell biosynthesis of glycan-based cell membrane components.
Identifiants
pubmed: 39009605
doi: 10.1038/s41598-024-65939-9
pii: 10.1038/s41598-024-65939-9
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Comparative Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
16300Informations de copyright
© 2024. The Author(s).
Références
Castelnuovo, P. & Turri-Zanoni, M. Adenoid cystic carcinoma. Adv. Otorhinolaryngol. 84, 197–209 (2020).
pubmed: 32731238
Cantu, G. Adenoid cystic carcinoma. An indolent but aggressive tumor. Part A: From aetiopathogenesis to diagnosis. Acta Otorhinolaryngol. Ital. 41(3), 206–214 (2021).
pubmed: 34264913
pmcid: 8283400
doi: 10.14639/0392-100X-N1379
de Morais, E. F. et al. Prognostic factors and survival in adenoid cystic carcinoma of the head and neck: A retrospective clinical and histopathological analysis of patients seen at a cancer center. Head Neck Pathol. 15(2), 416–424 (2021).
pubmed: 32779101
doi: 10.1007/s12105-020-01210-7
Ferrarotto, R. et al. Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets. Clin. Cancer Res. 27(3), 852–864 (2021).
pubmed: 33172898
doi: 10.1158/1078-0432.CCR-20-1192
Cantu, G. Adenoid cystic carcinoma. An indolent but aggressive tumor. Part B: Treatment and prognosis. Acta Otorhinolaryngol. Ital. 41(4), 296–307 (2021).
pubmed: 34533533
pmcid: 8448184
doi: 10.14639/0392-100X-N1729
Jiang, Q. et al. Salivary microbiome in adenoid cystic carcinoma detected by 16S rRNA sequencing and shotgun metagenomics. Front. Cell Infect. Microbiol. 11, 774453 (2021).
pubmed: 34970508
pmcid: 8712576
doi: 10.3389/fcimb.2021.774453
Pani, G. Fusobacterium & Co. at the stem of cancer: Microbe-cancer stem cell interactions in colorectal carcinogenesis. Cancers (Basel) 15(9), 2583 (2023).
pubmed: 37174049
doi: 10.3390/cancers15092583
Michikawa, C. et al. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1). Neoplasia 31, 100813 (2022).
pubmed: 35834946
pmcid: 9287628
doi: 10.1016/j.neo.2022.100813
Guan, S. W., Lin, Q. & Yu, H. B. Intratumour microbiome of pancreatic cancer. World J. Gastrointest. Oncol. 15(5), 713–730 (2023).
pubmed: 37275446
pmcid: 10237023
doi: 10.4251/wjgo.v15.i5.713
McAllister, F. et al. The tumor microbiome in pancreatic cancer: Bacteria and beyond. Cancer Cell 36(6), 577–579 (2019).
pubmed: 31951558
doi: 10.1016/j.ccell.2019.11.004
Han, M. et al. Vaginal and tumor microbiomes in gynecological cancer (review). Oncol. Lett. 25(4), 153 (2023).
pubmed: 36936020
pmcid: 10018329
doi: 10.3892/ol.2023.13739
Gihawi, A., et al. Major data analysis errors invalidate cancer microbiome findings. bioRxiv (2023).
Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368(6494), 973–980 (2020).
pubmed: 32467386
pmcid: 7757858
doi: 10.1126/science.aay9189
Schorr, L. et al. Intracellular bacteria in cancer-prospects and debates. NPJ Biofilms Microbiomes 9(1), 76 (2023).
pubmed: 37813921
pmcid: 10562400
doi: 10.1038/s41522-023-00446-9
Liu, W. et al. Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis. Gastroenterology 160(7), 2395–2408 (2021).
pubmed: 33581124
doi: 10.1053/j.gastro.2021.02.020
Pirini, F. et al. Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota. Front. Cell Dev. Biol. 10, 1048360 (2022).
pubmed: 36684442
doi: 10.3389/fcell.2022.1048360
Xue, C. et al. Current understanding of the intratumoral microbiome in various tumors. Cell Rep. Med. 4(1), 100884 (2023).
pubmed: 36652905
pmcid: 9873978
doi: 10.1016/j.xcrm.2022.100884
Jiang, Z. et al. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. Cancer Lett. 554, 216031 (2023).
pubmed: 36481214
doi: 10.1016/j.canlet.2022.216031
Liang, Y. et al. Awareness of intratumoral bacteria and their potential application in cancer treatment. Discov. Oncol. 14(1), 57 (2023).
pubmed: 37148441
pmcid: 10164222
doi: 10.1007/s12672-023-00670-x
Dawes, C. et al. The functions of human saliva: A review sponsored by the World Workshop on Oral Medicine VI. Arch. Oral. Biol. 60(6), 863–874 (2015).
pubmed: 25841068
doi: 10.1016/j.archoralbio.2015.03.004
Medeiros, M. C. et al. Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer. Microbiome 11(1), 268 (2023).
pubmed: 38037123
pmcid: 10687843
doi: 10.1186/s40168-023-01677-w
Cross, B. W. & Ruhl, S. Glycan recognition at the saliva—Oral microbiome interface. Cell Immunol. 333, 19–33 (2018).
pubmed: 30274839
pmcid: 6296888
doi: 10.1016/j.cellimm.2018.08.008
Gibbons, R. J. Adherent interactions which may affect microbial ecology in the mouth. J. Dent. Res. 63(3), 378–385 (1984).
pubmed: 6583240
doi: 10.1177/00220345840630030401
Gilbert, J.A., Jansson, J.K., Knight, R. Earth microbiome project and global systems biology. mSystems. 3(3) (2018).
Hall, M. & Beiko, R. G. 16S rRNA gene analysis with QIIME2. Methods Mol. Biol. 1849, 113–129 (2018).
pubmed: 30298251
doi: 10.1007/978-1-4939-8728-3_8
Rognes, T. et al. VSEARCH: A versatile open source tool for metagenomics. PeerJ 4, e2584 (2016).
pubmed: 27781170
pmcid: 5075697
doi: 10.7717/peerj.2584
Edgar, R. C. UNOISE2: improved error-correction for Illumina 16S and ITS amplicon sequencing. bioRxiv. 081257 (2016).
Yilmaz, P. et al. The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks. Nucleic Acids Res. 42(D1), D643–D648 (2013).
pubmed: 24293649
pmcid: 3965112
doi: 10.1093/nar/gkt1209
Lahti, L. et al. Tipping elements in the human intestinal ecosystem. Nat. Commun. 5(1), 4344 (2014).
pubmed: 25003530
doi: 10.1038/ncomms5344
Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17(11), e1009442 (2021).
pubmed: 34784344
pmcid: 8714082
doi: 10.1371/journal.pcbi.1009442
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12(6), R60 (2011).
pubmed: 21702898
pmcid: 3218848
doi: 10.1186/gb-2011-12-6-r60
de Hoon, M. J. L. et al. Open source clustering software. Bioinformatics 20(9), 1453–1454 (2004).
pubmed: 14871861
doi: 10.1093/bioinformatics/bth078
Anderson, M. J. A new method for non-parametric multivariate analysis of variance. Aust. Ecol. 26(1), 32–46 (2001).
Oksanen, J. S. G., Blanchet, F., Kindt, R., Legendre, P., Minchin, P, et al. vegan: Community Ecology Package. (2022).
Terry, M., Therneau, P. M. G. Modeling Survival Data: Extending the Cox Model. (2000).
Kassambara, A., Kosinski, M., Scheipl Fabian, P. B. survminer: Drawing Survival Curves using 'ggplot2'. (2021).
Hochberg, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75(4), 800–802 (1988).
doi: 10.1093/biomet/75.4.800
Sergushichev, A. A. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. bioRxiv. 060012 (2016).
Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587-d592 (2023).
pubmed: 36300620
doi: 10.1093/nar/gkac963
Ashburner, M. et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25(1), 25–29 (2000).
pubmed: 10802651
pmcid: 3037419
doi: 10.1038/75556
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27(12), 1739–1740 (2011).
pubmed: 21546393
pmcid: 3106198
doi: 10.1093/bioinformatics/btr260
Gihawi, A. et al. Major data analysis errors invalidate cancer microbiome findings. mBio 14(5), e0160723 (2023).
pubmed: 37811944
doi: 10.1128/mbio.01607-23
Nurk, S. et al. The complete sequence of a human genome. Science 376(6588), 44–53 (2022).
pubmed: 35357919
pmcid: 9186530
doi: 10.1126/science.abj6987
Colaprico, A. et al. TCGAbiolinks: An R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44(8), e71 (2016).
pubmed: 26704973
doi: 10.1093/nar/gkv1507
Rojas-Tapias, D. F. et al. Inflammation-associated nitrate facilitates ectopic colonization of oral bacterium Veillonella parvula in the intestine. Nat. Microbiol. 7(10), 1673 (2022).
pubmed: 36138166
pmcid: 9728153
doi: 10.1038/s41564-022-01224-7
Antezack, A. et al. Isolation and description of Catonella massiliensis sp. Nov., a Novel Catonella species, isolated from a stable periodontitis subject. Pathogens 10(3), 367 (2021).
pubmed: 33808593
pmcid: 8003473
doi: 10.3390/pathogens10030367
Mahlen, S. D. & Clarridge, J. E. 3rd. Site and clinical significance of Alloscardovia omnicolens and Bifidobacterium species isolated in the clinical laboratory. J. Clin. Microbiol. 47(10), 3289–3293 (2009).
pubmed: 19641056
pmcid: 2756926
doi: 10.1128/JCM.00555-09
Zhou, J. et al. The relationship of Megamonas species with nonalcoholic fatty liver disease in children and adolescents revealed by metagenomics of gut microbiota. Sci. Rep. 12(1), 22001 (2022).
pubmed: 36539432
pmcid: 9767906
doi: 10.1038/s41598-022-25140-2
Proctor, C. R., Edwards, M. A. & Pruden, A. Microbial composition of purified waters and implications for regrowth control in municipal water systems. Environ. Sci. Water Res. Technol. 1(6), 882–892 (2015).
doi: 10.1039/C5EW00134J
LaCroce, S. J. et al. Moraxella nonliquefaciens and M. osloensis are important Moraxella species that cause ocular infections. Microorganisms 7(6), 163 (2019).
pubmed: 31167433
pmcid: 6616425
doi: 10.3390/microorganisms7060163
Curtis, M. M. et al. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16(6), 759–769 (2014).
pubmed: 25498343
pmcid: 4269104
doi: 10.1016/j.chom.2014.11.005
Zhuo, D., Li, X. & Guan, F. Biological roles of aberrantly expressed glycosphingolipids and related enzymes in human cancer development and progression. Front. Physiol. 9, 466 (2018).
pubmed: 29773994
pmcid: 5943571
doi: 10.3389/fphys.2018.00466
D’Angelo, G. et al. Glycosphingolipids: Synthesis and functions. FEBS J. 280(24), 6338–6353 (2013).
pubmed: 24165035
doi: 10.1111/febs.12559
Cumin, C. et al. Deciphering the importance of glycosphingolipids on cellular and molecular mechanisms associated with epithelial-to-mesenchymal transition in cancer. Biomolecules 11(1), 62 (2021).
pubmed: 33418847
pmcid: 7824851
doi: 10.3390/biom11010062
Cumin, C. et al. Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways. Cell Rep. 40(7), 111181 (2022).
pubmed: 35977490
doi: 10.1016/j.celrep.2022.111181
Kiseleva, A. A., Nikonova, A. S. & Golemis, E. A. Patterns of ciliation and ciliary signaling in cancer. Rev. Physiol. Biochem. Pharmacol. 185, 87–105 (2023).
pubmed: 32761455
pmcid: 9916338
doi: 10.1007/112_2020_36
Segata, N. et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 13(6), R42 (2012).
pubmed: 22698087
pmcid: 3446314
doi: 10.1186/gb-2012-13-6-r42
van Elsas, J. D. et al. Microbial diversity determines the invasion of soil by a bacterial pathogen. Proc. Natl. Acad. Sci. U. S. A. 109(4), 1159–1164 (2012).
pubmed: 22232669
pmcid: 3268289
doi: 10.1073/pnas.1109326109
Riquelme, E. et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178(4), 795-806 e12 (2019).
pubmed: 31398337
pmcid: 7288240
doi: 10.1016/j.cell.2019.07.008
Konopka, A. What is microbial community ecology?. ISME J. 3(11), 1223–1230 (2009).
pubmed: 19657372
doi: 10.1038/ismej.2009.88
Kanamoto, T., Terakubo, S. & Nakashima, H. Antimicrobial susceptibilities of oral isolates of abiotrophia and granulicatella according to the consensus guidelines for fastidious bacteria. Medicines (Basel) 5(4), 129 (2018).
pubmed: 30514000
doi: 10.3390/medicines5040129
Galluzzi, L. et al. Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses. Oncogene 32(42), 4995–5004 (2013).
pubmed: 23334322
doi: 10.1038/onc.2012.623
Kareiva, P. Entire encyclopedia devoted to biodiversity. Trends Ecol. Evol. 16(5), 227 (2001).
pubmed: 11301150
Shin, N. R., Whon, T. W. & Bae, J. W. Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33(9), 496–503 (2015).
pubmed: 26210164
doi: 10.1016/j.tibtech.2015.06.011
Litvak, Y. et al. Dysbiotic Proteobacteria expansion: A microbial signature of epithelial dysfunction. Curr. Opin. Microbiol. 39, 1–6 (2017).
pubmed: 28783509
doi: 10.1016/j.mib.2017.07.003
Rizzatti, G. et al. Proteobacteria: A common factor in human diseases. Biomed. Res. Int. 2017, 9351507 (2017).
pubmed: 29230419
pmcid: 5688358
doi: 10.1155/2017/9351507
Chakladar, J. et al. The pancreatic microbiome is associated with carcinogenesis and worse prognosis in males and smokers. Cancers (Basel) 12(9), 2672 (2020).
pubmed: 32962112
doi: 10.3390/cancers12092672
Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51, 102590 (2020).
pubmed: 31901868
pmcid: 6948163
doi: 10.1016/j.ebiom.2019.11.051
Park, S. Y. et al. Oral-gut microbiome axis in gastrointestinal disease and cancer. Cancers (Basel) 13(9), 2124 (2021).
pubmed: 33924899
doi: 10.3390/cancers13092124
Kitamoto, S. et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell 182(2), 447-462.e14 (2020).
pubmed: 32758418
pmcid: 7414097
doi: 10.1016/j.cell.2020.05.048
Flemer, B. et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut 67(8), 1454–1463 (2018).
pubmed: 28988196
doi: 10.1136/gutjnl-2017-314814
Msaddak, A. et al. Phylogenetic analyses of rhizobia isolated from nodules of Lupinus angustifolius in Northern Tunisia reveal Devosia sp. as a new microsymbiont of Lupin species. Agronomy-Basel 11(8), 1510 (2021).
doi: 10.3390/agronomy11081510
Chrisman, B. et al. The human “contaminome”: Bacterial, viral, and computational contamination in whole-genome sequences from 1000 families. Sci. Rep. 12(1), 9863 (2022).
pubmed: 35701436
pmcid: 9198055
doi: 10.1038/s41598-022-13269-z
Laurence, M., Hatzis, C. & Brash, D. E. Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes. PLoS One 9(5), e97876 (2014).
pubmed: 24837716
pmcid: 4023998
doi: 10.1371/journal.pone.0097876
Glover, J. S., Ticer, T. D. & Engevik, M. A. Characterizing the mucin-degrading capacity of the human gut microbiota. Sci. Rep. 12(1), 8456 (2022).
pubmed: 35589783
pmcid: 9120202
doi: 10.1038/s41598-022-11819-z
Karpinets, T. V. et al. Whole-genome sequencing of common salivary gland carcinomas: Subtype-restricted and shared genetic alterations. Clin. Cancer Res. 27(14), 3960–3969 (2021).
pubmed: 34011559
pmcid: 8598082
doi: 10.1158/1078-0432.CCR-20-4071
Zalewska, A. et al. Structure and biosynthesis of human salivary mucins. Acta Biochim. Pol. 47(4), 1067–1079 (2000).
pubmed: 11996097
doi: 10.18388/abp.2000_3960
Karpinets, T. V. et al. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer 22(1), 945 (2022).
pubmed: 36050658
pmcid: 9438314
doi: 10.1186/s12885-022-09997-0
Bell, A. & Juge, N. Mucosal glycan degradation of the host by the gut microbiota. Glycobiology 31(6), 691–696 (2021).
pubmed: 33043970
doi: 10.1093/glycob/cwaa097